Building on strengths, growth prospects buoyant
JUBI’s FY21 annual report highlights the management’s efforts to stay ahead of its peers and reap the treme..
Second wave impacts sales volume…
About the stock: Brigade Enterprises (BEL) is one of the leading property developers in South India. Distinguished reputation ..
Margin challenges likely to persist
Bosch’s (BOS) Q1FY22 operating performance was ahead of consensus estimates as adj. EBITDA margin fell just 176bps QoQ to 12...
Bharti approves INR210b right issue
Contours of the issue
The right issue will be at INR535/share, at a 1:14 ratio, implying a 7% equity dilution. It is at a mere 1..
Saturation of an earnings lever
Novelis reported an inline adjusted EBITDA of US$508mn in Q1FY22 (EBITDA/te of US$522/te). EBITDA was buffered by US$47mn of favourable..
Novel chemistry at play
* Clean Science and Technology (CSTL) recently concluded its IPO via an offer for sale of INR15.5b, priced at INR900/share. Post the IPO the pr..
Q1 miss; outlook intact
Solara Active Pharma (Solara) reported Q1FY22 performance was below estimate due to demand pressure in some products including Ibuprofen in the..
Margin-led earnings miss; order inflows robust
Balance Sheet strength intact
* Revenue was in line with our estimate in 1QFY22, with a miss (15%) on operating profi..
Near term outlook cautious amid global chip shortage
About the stock: Bosch Ltd (Bosch) is a technology leader providing solutions in automotive, industrial technology..
Cost savings and operating leverage lower operating loss
Revenue/EBITDA above our estimate
* Despite the second COVID wave, standalone RevPAR nearly doubled as comp..
NPA resilience continues; improving outlook…
About the stock: SBI is a public sector bank and also the largest bank in India with a balance sheet size of over |..
Buy Gujarat State Petronet Ltd For Target Rs.500
Volume recovery ahead of our estimate
* GUJS reported a marginally higher (+5%) transmission volume than our estima..
Rupee falls 10 paise to 73.94 against US dollar in early trade
Rupee strengthens against US dollar on Tuesday
Rate decision, US stimulus likely constraints to rupee's further appreciation
Rupee slips on RBI's dovish stance, 'loose' policy
Currency Squeeze: Rupee expected to weaken further
Pharma Sector Update - IPM growth momentum picks up By Emkay Global
Sell Cocudakl Below 2400 SL Above 2430 TGT 2370/2340 - Axis Securities Ltd
Real Estate Sector Update - We highlight this week`s top real estate news By JM Financial
No change in fuel prices for 16th consecutive day
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface